Status:
UNKNOWN
Validation of the Diagnostic Accuracy of the Electronic Nose in the Detection of Thyroid Cancer
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Thyroid Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
Patients with a suspected thyroid nodule face an invasive and patient unfriendly diagnostic work-up to determine the risk of malignancy. Typically, patients undergo ultrasound of the thyroid gland fol...
Detailed Description
Thyroid cancer is the most common endocrine cancer worldwide. In most developed countries, the incidence of thyroid cancer has rapidly increased in the last three decades In the Netherlands, 700 patie...
Eligibility Criteria
Inclusion
- Thyroid nodule requiring additional diagnostic follow-up (TI-RADS/Bethesda)
- Patients with thyroid problems requiring surgery (e.g. goiter)
- AeonoseTM measurement before undergoing cytological puncture or at least 3 days after cytological puncture pre-operatively.
- \> 18 year.
- Signed informed consent
Exclusion
- Other underlying malignancy, (less than 5 years ago), basal cell carcinoma not included - Unable to participate due to comorbidities (e.g. COPD)
- Not able to understand the information
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04883294
Start Date
May 1 2021
End Date
January 1 2025
Last Update
May 12 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.